Tivorsan Pharmaceuticals Inc. has received orphan drug designation from the U.S. Food and Drug Administration for a drug used in the treatment of Duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle degeneration and weakness.
In the fifth edition of Providence Business News’ Healthiest Employers celebration event, 28 local employers were recognized for their efforts – and successes – in creating healthy workplaces for their employees.
(Updated 3:26 p.m.)
Rhode Island received an overall grade of B- in a recent report from the College and University Research Collaborative that evaluated the performance of state health insurance marketplaces.
(Updated 12:55 p.m. and 3:39 p.m.)
New Bedford and Fall River mayors are being asked by Massachusetts health care workers, labor leaders and social justice advocates to hold additional meetings about the proposed merger between Southcoast Health and Care New England.